Sidewinder Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2023

Sidewinder Therapeutics is a biotechnology company dedicated to developing precision biologics aimed at treating cancer and rare diseases. The company operates in the therapeutics market, focusing on large molecule drugs that target specific molecular drivers of disease. Sidewinder's business model revolves around drug discovery and development, leveraging the expertise of a dynamic team of serial entrepreneurs and expert scientists. Revenue is generated through the advancement and commercialization of innovative medicines designed to improve patient outcomes. The company serves patients with unmet medical needs, particularly those suffering from complex conditions that require targeted therapeutic interventions. Sidewinder's commitment to delivering life-saving therapies is underscored by its leadership team's extensive experience in the field. Keywords: precision biologics, cancer, rare diseases, drug discovery, large molecule, molecular drivers, therapeutics, patient outcomes, biotechnology, drug development.

Valuation $500M–1B

Headcount <100

Total funding $100–500M

Unlock exact values

Investors

9 investors on Sidewinder Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 9 investors entered at this stage

OrbiMed

Frazier Life Sciences

Novartis Venture Fund

Longwood Fund

Astellas Venture

Alexandria Venture Investments

Goldman Sachs Asset Management

Samsara BioCapital

DCVC Bio

Global footprint

Where Sidewinder Therapeutics has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Talent graph

The shape of Sidewinder Therapeutics's talent

Dealroom maps Sidewinder Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

2 team members profilednamed & role-tagged by Dealroom

9 employeestotal headcount

2 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Sidewinder Therapeutics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Sidewinder Therapeutics

An AI-synthesized read of the highest-engagement posts about Sidewinder Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sidewinder Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles